June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Utility of endophenotypic variants in a glaucoma genetic risk score
Author Affiliations & Notes
  • Anna Neustaeter
    Ophthalmology, University Medical Centre Groningen, Groningen, Groningen, Netherlands
  • Anna Leonte
    Ophthalmology, University Medical Centre Groningen, Groningen, Groningen, Netherlands
  • Ilja Nolte
    Epidemiology, University Medical Centre Groningen, Groningen, Netherlands
  • Nomdo M Jansonius
    Ophthalmology, University Medical Centre Groningen, Groningen, Groningen, Netherlands
  • Harold Snieder
    Epidemiology, University Medical Centre Groningen, Groningen, Netherlands
  • Footnotes
    Commercial Relationships   Anna Neustaeter, None; Anna Leonte, None; Ilja Nolte, None; Nomdo Jansonius, None; Harold Snieder, None
  • Footnotes
    Support  Marie Curie cofund, grant number O-550433
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 57. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anna Neustaeter, Anna Leonte, Ilja Nolte, Nomdo M Jansonius, Harold Snieder; Utility of endophenotypic variants in a glaucoma genetic risk score. Invest. Ophthalmol. Vis. Sci. 2020;61(7):57.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To obtain the increased risk and additionally explained variance of endophenotypic variants added to a glaucoma genetic risk score, based on a glaucoma meta genome-wide association study (GWAS).

Methods : We searched the literature for GWAS for glaucoma and related endophenotypes (intraocular pressure [IOP], central corneal thickness [CCT], and optic disc/cup parameters) in Caucasians. The summary statistics of a large glaucoma meta-GWAS were used to create a weighted glaucoma genetic risk score (GRS); variant effect-sizes were multiplied by genotype dosages and summed within a case-control cohort. Endophenotypic variants were weighted for the glaucoma meta-GWAS effect and subsequently added to the GRS. Cases (n=734) were obtained from the Groningen Longitudinal Glaucoma study, and controls (n=1,418) were obtained from the Groningen Expert Center for Kids with Obesity cohort. Adjusted odds ratios (ORs) per standard deviation increase in genetic risk were calculated, in addition to Nagelkerke’s Pseudo R2 and receiver operating characteristic (ROC) curves.

Results : We obtained 47 genome-wide significant variants from the meta-GWAS, 4 additional glaucoma variants, 200 IOP variants, 13 CCT variants, and 4 disc/cup variants, totaling 268 variants of interest. Per standard deviation increase in genetic risk, the OR for glaucoma increased from 1.66, P=6.5*10-25 with glaucoma variants only, to 2.11 P=2.2*10-44 with endophenotypic variants added. The explained variance increased from 7.2% with only glaucoma variants to 14.1% with endophenotypic variants. Associated area under the curves (AUCs) ranged from 63.6% with glaucoma variants to 69.2% with endophenotypic variants added.

Conclusions : The addition of endophenotypic variants to a glaucoma genetic risk score increases both the OR and variance explained. The inclusion of all informative variants for glaucoma genetic risk may improve future population-based genetic screening programs.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×